Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 22, 2020 Filed Sep 23, 2020 16:21 UTC GrantPhantom Stock Unit · Derivative 154.7892 $161.51 $25,000.00
Disclosure

SEC source: 0001555280-20-000280 · wf-form4_160089249626566.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,232.9114

Underlying: Common Stock · 154.7892 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 16:18 UTC
Rhodes LindaDirector
SaleCommon Stock 1,087 $159.16 $173,006.92
Disclosure

SEC source: 0001555280-20-000273 · wf-form4_159959628473330.xml · nonDerivative · entry 1

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,468

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:48 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000271 · wf-form4_159907967840830.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,407

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 3,538 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:48 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $160.71 $189,477.09
Disclosure

SEC source: 0001555280-20-000271 · wf-form4_159907967840830.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:48 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 1,179 $41.83 $49,317.57
Disclosure

SEC source: 0001555280-20-000271 · wf-form4_159907967840830.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

Read SEC document
August 25, 2020 Filed Aug 26, 2020 22:00 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionStock Option · Derivative 6,500 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,685

Underlying: Common Stock · 6,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 6,500 options granted March 4, 2014 at an exercise price of $30.89 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 69,536 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
August 25, 2020 Filed Aug 26, 2020 22:00 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 5,699 $157.86 $899,644.14
Disclosure

SEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,874

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.64 to $157.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2020 Filed Aug 26, 2020 22:00 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 4,801 $157.31 $755,245.31
Disclosure

SEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,573

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.64 to $157.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2020 Filed Aug 26, 2020 22:00 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,500 $30.89 $200,785.00
Disclosure

SEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:27 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,598

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 6,000 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 13,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:27 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 6,000 $160.37 $962,220.00
Disclosure

SEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.04 to $161.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:27 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 6,000 $41.83 $250,980.00
Disclosure

SEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.

Read SEC document
August 13, 2020 Filed Aug 17, 2020 16:23 UTC SaleCommon Stock 1,885 $159.07 $299,846.95
Disclosure

SEC source: 0001555280-20-000264 · wf-form4_159769579155510.xml · nonDerivative · entry 1

Reed Willie M · CIK 0001601695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,635

Read SEC document
August 13, 2020 Filed Aug 17, 2020 20:26 UTC
Knupp Catherine A.Executive Vice President
SaleCommon Stock 3,000 $159.52 $478,560.00
Disclosure

SEC source: 0001555280-20-000265 · wf-form4_159769598579511.xml · nonDerivative · entry 2

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,368

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.13 to $159.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 13, 2020 Filed Aug 17, 2020 20:26 UTC
Knupp Catherine A.Executive Vice President
SaleCommon Stock 10,000 $158.66 $1,586,600.00
Disclosure

SEC source: 0001555280-20-000265 · wf-form4_159769598579511.xml · nonDerivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,368

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.12 to $159.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 17:32 UTC
Rhodes LindaDirector
Exercise / conversionRestricted Stock Unit · Derivative 3,270.0727 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-20-000251 · wf-form4_159657644567811.xml · derivative · entry 3

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,023.2396

Underlying: Common Stock · 3,270.0727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,270.0727 RSUs vested on August 3, 2020; 2,771.4602 RSUs will vest on February 13, 2021; 2,651.1276 RSUs will vest on February 12, 2022; and 1,600.6518 RSUs will vest on February 11, 2023.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,270.0727 RSUs vested on August 3, 2020; 2,771.4602 RSUs will vest on February 13, 2021; 2,651.1276 RSUs will vest on February 12, 2022; and 1,600.6518 RSUs will vest on February 11, 2023.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,270.0727 RSUs vested on August 3, 2020; 2,771.4602 RSUs will vest on February 13, 2021; 2,651.1276 RSUs will vest on February 12, 2022; and 1,600.6518 RSUs will vest on February 11, 2023.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 17:32 UTC
Rhodes LindaDirector
OtherCommon Stock 720 $154.51 $111,247.20
Disclosure

SEC source: 0001555280-20-000251 · wf-form4_159657644567811.xml · nonDerivative · entry 2

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 17:32 UTC
Rhodes LindaDirector
Exercise / conversionCommon Stock 3,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-20-000251 · wf-form4_159657644567811.xml · nonDerivative · entry 1

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 20:31 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000249 · wf-form4_159657299079765.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,586

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 4,717 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
August 03, 2020 Filed Aug 4, 2020 20:31 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $152.19 $179,432.01
Disclosure

SEC source: 0001555280-20-000249 · wf-form4_159657299079765.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

Read SEC document
August 03, 2020 Filed Aug 4, 2020 20:31 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 1,179 $41.83 $49,317.57
Disclosure

SEC source: 0001555280-20-000249 · wf-form4_159657299079765.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:32 UTC
PECK KRISTIN CDirector · Chief Executive Officer
GrantPhantom Stock Unit · Derivative 327.0981 $45.27 $14,807.73
Disclosure

SEC source: 0001555280-20-000237 · wf-form4_159536351623390.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,044.0586

Underlying: Common Stock · 102.3623 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 22:53 UTC
McFarland James MichaelExecutive Vice President
GrantPhantom Stock Unit · Derivative 32.9362 $45.27 $1,491.02
Disclosure

SEC source: 0001555280-20-000246 · wf-form4_159537196219303.xml · derivative · entry 1

McFarland James Michael · CIK 0001801162 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,412.9231

Underlying: Common Stock · 10.3071 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F3 · balance_after: Includes 69.6 phantom stock units inadvertently omitted from the reporting person's Form 4 filed on April 2, 2020.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:51 UTC
Bettington Timothy JExecutive Vice President
GrantPhantom Stock Unit · Derivative 156.1153 $45.27 $7,067.34
Disclosure

SEC source: 0001555280-20-000244 · wf-form4_159536466499393.xml · derivative · entry 1

Bettington Timothy J · CIK 0001797894 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259.8523

Underlying: Common Stock · 48.8548 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:48 UTC
Knupp Catherine A.Executive Vice President
GrantPhantom Stock Unit · Derivative 211.1272 $45.27 $9,557.73
Disclosure

SEC source: 0001555280-20-000243 · wf-form4_159536452469709.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,267.7892

Underlying: Common Stock · 66.0703 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:46 UTC
Mamilli WafaaExecutive Vice President
GrantPhantom Stock Unit · Derivative 178.4173 $45.27 $8,076.95
Disclosure

SEC source: 0001555280-20-000242 · wf-form4_159536437778152.xml · derivative · entry 1

Mamilli Wafaa · CIK 0001800960 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,518.5943

Underlying: Common Stock · 55.834 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:43 UTC
Chen Heidi C.Executive Vice President
GrantPhantom Stock Unit · Derivative 182.8783 $45.27 $8,278.90
Disclosure

SEC source: 0001555280-20-000241 · wf-form4_159536421093476.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,360.4307

Underlying: Common Stock · 57.2301 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:41 UTC
Kelly Robert EdwardExecutive Vice President
GrantPhantom Stock Unit · Derivative 156.1153 $45.27 $7,067.34
Disclosure

SEC source: 0001555280-20-000240 · wf-form4_159536405431970.xml · derivative · entry 1

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,113.7003

Underlying: Common Stock · 48.8548 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:35 UTC
David GlennChief Financial Officer
GrantPhantom Stock Unit · Derivative 215.5882 $45.27 $9,759.68
Disclosure

SEC source: 0001555280-20-000238 · wf-form4_159536373087975.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,056.8293

Underlying: Common Stock · 67.4663 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:38 UTC GrantPhantom Stock Unit · Derivative 61.1716 $45.27 $2,769.24
Disclosure

SEC source: 0001555280-20-000239 · wf-form4_159536389884395.xml · derivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,083.6325

Underlying: Common Stock · 19.1431 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 20:29 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 166.5233 $45.27 $7,538.51
Disclosure

SEC source: 0001555280-20-000236 · wf-form4_159536337559576.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,601.6293

Underlying: Common Stock · 52.1119 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 22:18 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionStock Option · Derivative 4,079 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · derivative · entry 3

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,577

Underlying: Common Stock · 4,079 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,079 options granted February 14, 2017 at an exercise price of $55.02 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 4,080 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 22:18 UTC
Trawicki RomanExecutive Vice President
SaleCommon Stock 5,499 $137.29 $754,957.71
Disclosure

SEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · nonDerivative · entry 2

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,421

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 22:18 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionCommon Stock 4,079 $55.02 $224,426.58
Disclosure

SEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · nonDerivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 22:13 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000225 · wf-form4_159372797108332.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,765

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 5,896 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 22:13 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $137.29 $161,864.91
Disclosure

SEC source: 0001555280-20-000225 · wf-form4_159372797108332.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

Read SEC document
July 01, 2020 Filed Jul 2, 2020 22:13 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 1,179 $41.83 $49,317.57
Disclosure

SEC source: 0001555280-20-000225 · wf-form4_159372797108332.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

Read SEC document
June 23, 2020 Filed Jun 24, 2020 16:25 UTC GrantPhantom Stock Unit · Derivative 181.0151 $138.11 $25,000.00
Disclosure

SEC source: 0001555280-20-000218 · wf-form4_159303028870709.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,057.3047

Underlying: Common Stock · 181.0151 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 20:18 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000216 · wf-form4_159112910980681.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,944

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 7,075 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 20:18 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 1,179 $138.65 $163,468.35
Disclosure

SEC source: 0001555280-20-000216 · wf-form4_159112910980681.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,335

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 20:18 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 1,179 $41.83 $49,317.57
Disclosure

SEC source: 0001555280-20-000216 · wf-form4_159112910980681.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

Read SEC document
May 26, 2020 Filed May 28, 2020 20:29 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionStock Option · Derivative 6,500 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · derivative · entry 5

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,185

Underlying: Common Stock · 6,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 3,885 options granted January 31, 2013 at an exercise price of $26.00 per option and 2,615 options granted March 4, 2014 at an exercise price of $30.89 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 76,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
May 26, 2020 Filed May 28, 2020 20:29 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 2,800 $131.65 $368,620.00
Disclosure

SEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,874

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.46 to $131.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 26, 2020 Filed May 28, 2020 20:29 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 7,700 $131.19 $1,010,163.00
Disclosure

SEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,674

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.43 to $131.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 26, 2020 Filed May 28, 2020 20:29 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,615 $30.89 $80,777.35
Disclosure

SEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 26, 2020 Filed May 28, 2020 20:29 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,885 $26.00 $101,010.00
Disclosure

SEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,759

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019.

Read SEC document
May 19, 2020 Filed May 21, 2020 20:19 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 4,463 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,598

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document
May 19, 2020 Filed May 21, 2020 20:19 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 4,463 $131.02 $584,742.26
Disclosure

SEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.39 to $131.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2020 Filed May 21, 2020 20:19 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 4,463 $46.09 $205,699.67
Disclosure

SEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,143

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

Read SEC document
May 01, 2020 Filed May 4, 2020 20:49 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 1,179 $0.00 $0.00
Disclosure

SEC source: 0001555280-20-000192 · wf-form4_158862533753154.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,123

Underlying: Common Stock · 1,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 8,254 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.